Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database
- PMID: 16386668
- DOI: 10.1016/j.jacc.2005.09.022
Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database
Erratum in
- J Am Coll Cardiol. 2006 Apr 7;47(7):1502
Abstract
Approximately 50% of patients hospitalized for heart failure have preserved systolic function. These patients are more likely to be older, women, and hypertensive. Their duration of hospitalization is similar to that of heart failure patients with systolic dysfunction, but their in-hospital mortality risk is lower. This mortality risk is increased in the setting of renal insufficiency, and the two most important risk predictors are elevated blood urea nitrogen and systolic blood pressure < or = 125 mm Hg. Medical treatment strategies for patients with preserved systolic function are inconsistent and reflect the need for efficacious evidence-based treatment regimens.
Objectives: The aims of this analysis were to describe the clinical characteristics, management, and outcomes of patients hospitalized for acute decompensated heart failure (HF) with preserved systolic function (PSF).
Background: Clinically meaningful characteristics of these patients have not been fully studied in a large database.
Methods: Data from >100,000 hospitalizations from the Acute Decompensated Heart Failure National Registry (ADHERE) database were analyzed.
Results: Heart failure with PSF was present in 50.4% of patients with in-hospital assessment of left ventricular function. When compared with patients with systolic dysfunction, patients with PSF were more likely to be older, women, and hypertensive and less likely to have had a prior myocardial infarction or be receiving an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker. In-hospital mortality was lower in patients with PSF compared with patients with systolic dysfunction (2.8% vs. 3.9%; adjusted odds ratio [OR]: 0.86; p = 0.005), but duration of intensive care unit stay and total hospital length of stay were similar. Serum creatinine >2 mg/dl was associated with increased in-hospital mortality in both systolic function groups (PSF: 4.8%; systolic dysfunction: 8.4%; p < 0.0001), and the most powerful predictors of in-hospital mortality in both groups were blood urea nitrogen >37 mg/dl (OR: 2.53; 95% confidence interval [CI]: 2.22 to 2.87) and systolic blood pressure < or =125 mm Hg (OR: 2.58; 95% CI: 2.33 to 2.86).
Conclusions: Heart failure with PSF is common and is characterized by a unique patient profile. Event rates are worrisome and reflect a need for more effective management strategies.
Comment in
-
Examining the concept of preserved systolic function.J Am Coll Cardiol. 2006 Dec 19;48(12):2599-600. doi: 10.1016/j.jacc.2006.09.028. Epub 2006 Nov 22. J Am Coll Cardiol. 2006. PMID: 17174206 No abstract available.
Similar articles
-
Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.J Am Coll Cardiol. 2007 Aug 21;50(8):768-77. doi: 10.1016/j.jacc.2007.04.064. Epub 2007 Aug 6. J Am Coll Cardiol. 2007. PMID: 17707182
-
Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.J Am Coll Cardiol. 2007 May 15;49(19):1943-50. doi: 10.1016/j.jacc.2007.02.037. Epub 2007 Apr 30. J Am Coll Cardiol. 2007. PMID: 17498579
-
Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).J Card Fail. 2006 Mar;12(2):100-7. doi: 10.1016/j.cardfail.2005.09.005. J Card Fail. 2006. PMID: 16520256
-
Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis.J Am Coll Cardiol. 2004 Feb 4;43(3):317-27. doi: 10.1016/j.jacc.2003.07.046. J Am Coll Cardiol. 2004. PMID: 15013109 Review.
-
Treatment of heart failure with preserved systolic function.Arch Cardiovasc Dis. 2008 May;101(5):361-72. doi: 10.1016/j.acvd.2008.04.008. Epub 2008 Jul 7. Arch Cardiovasc Dis. 2008. PMID: 18656095 Review.
Cited by
-
The prognostic value of estimated glomerular filtration rate, amino-terminal portion of the pro-hormone B-type natriuretic peptide and parameters of cardiopulmonary exercise testing in patients with chronic heart failure.Heart Int. 2012 Jun 5;7(2):e13. doi: 10.4081/hi.2012.e13. Epub 2012 Jun 19. Heart Int. 2012. PMID: 23185680 Free PMC article.
-
Positive outcome of average volume-assured pressure support mode of a Respironics V60 Ventilator in acute exacerbation of chronic obstructive pulmonary disease: a case report.J Med Case Rep. 2012 Sep 10;6:284. doi: 10.1186/1752-1947-6-284. J Med Case Rep. 2012. PMID: 22963752 Free PMC article.
-
Narrative review: the holy grail: update on pharmacotherapy for heart failure with preserved ejection fraction.Ann Transl Med. 2021 Mar;9(6):523. doi: 10.21037/atm-20-4602. Ann Transl Med. 2021. PMID: 33850920 Free PMC article. Review.
-
Study protocol for the PURSUIT-HFpEF study: a Prospective, Multicenter, Observational Study of Patients with Heart Failure with Preserved Ejection Fraction.BMJ Open. 2020 Oct 15;10(10):e038294. doi: 10.1136/bmjopen-2020-038294. BMJ Open. 2020. PMID: 33060085 Free PMC article.
-
Pulmonary hypertension in patients with heart failure and preserved ejection fraction: differential diagnosis and management.Pulm Circ. 2016 Mar;6(1):3-14. doi: 10.1086/685021. Pulm Circ. 2016. PMID: 27162611 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous